首页> 外国专利> METHOD OF ESTIMATING INDIVIDUAL THERAPEUTIC RESPONSE EUBIOTICS WITH BACILLUS CEREUS STRAIN IP 5832 (ATSS 14893) AS PRIMARY ACTIVE PRINCIPLE WITH RESPECT TO OPPORTUNISTIC PATHOGENS RECOVERED FROM PATIENT EXAMINED FOR INTESTINAL DYSBACTERIOSIS

METHOD OF ESTIMATING INDIVIDUAL THERAPEUTIC RESPONSE EUBIOTICS WITH BACILLUS CEREUS STRAIN IP 5832 (ATSS 14893) AS PRIMARY ACTIVE PRINCIPLE WITH RESPECT TO OPPORTUNISTIC PATHOGENS RECOVERED FROM PATIENT EXAMINED FOR INTESTINAL DYSBACTERIOSIS

机译:评估以芽孢杆菌IP 5832(ATSS 14893)为主要活动原理,针对从肠道细菌性疾病患者中回收的机会性病原体的个体治疗反应药效学的方法

摘要

FIELD: medicine.;SUBSTANCE: there is involved a combined incubation in physiologic saline of recovered Bacillus cereus strain IP 5832 (ATSS 14893) in pure culture and recovered pure culture of opportunistic pathogen (OP) the patient's excrements. The prepared mixture is plated on nutrient agar with penicillin in concentration 0.01 Un/ml and without it, and if observing the decrease in OP count on the penicillin medium as compared with OP count on the non-penicillin medium, antagonistic activity of Bacillus cereus strain IP 5832 (ATSS 14893) with respect to OP strain is present, and an eubiotic is considered to show a therapeutic response on OP strain recovered from the patient examined for intestinal dysbacteriosis.;EFFECT: Bacillus cereus strain IP 5832 suppression without involving the OP test culture germination.;3 tbl, 5 ex
机译:领域:医学。物质:涉及在纯培养物中回收的蜡状芽孢杆菌IP 5832(ATSS 14893)菌株的生理盐水中和患者粪便中机会病原体(OP)的回收纯培养物中的生理盐水联合培养。将制备的混合物涂在浓度为0.01 Un / ml且不含青霉素的营养琼脂上,并且如果观察到青霉素培养基上OP计数与非青霉素培养基上OP计数相比降低,则蜡状芽孢杆菌菌株具有拮抗活性。存在针对OP菌株的IP 5832(ATSS 14893),并且认为优生菌对从接受检查的肠道菌群失调的患者中回收的OP菌株显示出治疗反应。效果:蜡状芽孢杆菌IP 5832菌株的抑制作用不涉及OP试验文化发芽。; 3汤匙,5前

著录项

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号